CALCIMEDICA INC. - COMMON STOCK

CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

10 8 2023 15:05:00 提供 Nasdaq GlobeNewswire

CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

09 8 2023 06:30:00 提供 Nasdaq GlobeNewswire

CalciMedica Announces Relisting on Nasdaq

12 6 2023 06:30:00 提供 Nasdaq GlobeNewswire

CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)

06 6 2023 06:30:18 提供 Nasdaq GlobeNewswire

CalciMedica Expands Executive Team with New Appointments

23 5 2023 06:30:00 提供 Nasdaq GlobeNewswire

CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

15 5 2023 07:55:00 提供 Nasdaq GlobeNewswire